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In Vivo Magnetic Resonance Imaging
Detection of Paramagnetic Liposomes
Loaded with Amphiphilic
Gadolinium(III) Complexes: Impact of
Molecular Structure on Relaxivity and
Excretion EfficiencyCreating an image : The in vivo perfor-
mance of liposomes loaded with differ-
ent amphiphilic Gd-based magnetic res-
onance imaging agents is compared in
a tumour model on mice. The tetracar-
boxylic complex GdDOTA(GAC12)2 (see
figure), which combines a fast rate of
water exchange and a restricted local
mobility, shows the highest sensitivity
detection and more favourable pharma-
cokinetic properties.
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Introduction
Magnetic resonance imaging (MRI) is one of the most powerful
non-invasive medical diagnostic procedures currently in use.
The superb spatial resolution and the outstanding capacity of
differentiating soft tissues justify the steadily growing clinical
relevance of this imaging modality. MRI is based on the detec-
tion of the NMR signal generated by water protons. Through
specific pulse sequences, the contrast is generated wherever
there is a difference in the longitudinal (T1) or transverse (T2)
relaxation times of tissue 1H2O. As the relaxation times are ex-
tremely sensitive to the biological environment of water mole-
cules, the MRI contrast can report on many structural and dy-
namic alterations associated with pathological states, even
without using exogenous contrast media.[1] However, if the en-
dogenous contrast between healthy and pathological regions
is poor, or if the imaging experiment is aimed at visualising
molecular events, the administration of imaging reporters be-
comes mandatory.[2] Clinically approved MRI contrast agents
are classified as T1 or T2 agents; the former group includes par-
amagnetic GdIII- or MnII-based complexes,[3] whereas the
second class mainly comprises superparamagnetic iron oxide
(SPIO) particles.[4]
The challenge of designing new highly sensitive T1 agents
has been pursued mainly through two approaches: 1) optimi-
sation of the dynamic and structural determinants that define
the efficacy to generate contrast by a single paramagnetic
The magnetic resonance imaging (MRI) performance of two
liposome formulations incorporating amphiphilic 1,4,7,10-tet-
raazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-like GdIII
complexes has been investigated both in vitro and in vivo. The
complexes differ in one donor group of the coordination cage
(carboxylate versus carboxoamide), and in the length (C12
versus C18) and the point of attachment of the aliphatic chains
to the chelators. The in vitro 1H relaxometric characterisation of
the systems, performed with a newly developed relaxation
model that takes into account the contributions of the GdIII
chelates pointing in- and outwards of the liposome, indicates
that their efficacy is optimal in the range 0.5–1.5 T. The tetra-
carboxylic C12-containing liposomes (LIPO-GdDOTA(GAC12)2 ;
GA=glutaric acid) are four-fold more efficient than the monoa-
mide C18-based analogue (LIPO-GdDOTAMA(C18)2). Such a differ-
ence is also found in vivo at 1 T in a melanoma tumour model
on mice. A few hours after intravenous injection, the T1 con-
trast enhancement in the organs where the nanovesicles typi-
cally distribute (liver, spleen, kidneys and tumour) is much
higher for LIPO-GdDOTA(GAC12)2. Interestingly, after about 7 h
post-injection the contrast enhancement observed for the
more efficient liposomes decreases rapidly and becomes lower
than for LIPO-GdDOTAMA(C18)2. The relaxometric data and the
quantification of the GdIII complexes in the organs, determined
ex vivo by inductively coupled plasma mass spectrometry, indi-
cate that: 1) the differences in the contrast enhancement can
be attributed to the different rate of water exchange and rota-
tional dynamics of the Gd complexes, and 2) the rapid contrast
decrease is caused by a faster clearance of GdDOTA(GAC12)2
from the organs. This is also confirmed by using a newly syn-
thesised amphiphilic cyanine-based fluorescent probe (Cy5-
(C16)2). As one of the main limitations for the clinical translation
of liposomes incorporating amphiphilic imaging agents is relat-
ed to their very long persistence in the body, the results re-
ported herein suggest that the clearance of the probes can be
accelerated, without compromising their role, by a proper se-
lection of the lipophilic portion of the incorporated compound
as well as of the ligand site at which the aliphatic tails are
linked. Then, GdDOTA(GAC12)2 complex may represent a good
candidate for the development of improved MRI protocols
based on paramagnetically labelled lipidic nanoparticles.
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centre, and 2) increasing the number of paramagnetic units
that can be delivered to a given biological target. The ability
of the paramagnetic agent to create T1 contrast in vivo is typi-
cally predicted by the value of its in vitro relaxivity (r1), which
corresponds to the paramagnetic longitudinal relaxation rate
of solvent water protons normalised to one millimolar concen-
tration of agent.[3] The r1 value has to be referred to a given
magnetic field strength, temperature and pH. In the last two
decades, great efforts have been made to shed light on the
molecular mechanisms underlying the paramagnetic relaxa-
tion, thus making possible the rational design of MRI probes
with improved sensitivity.[3,5] However, MRI visualisation of low-
concentration targets invariably implies the need to deliver
a high number of agent molecules. In turn, this requires that
a number of paramagnetic complexes have to be loaded on
a suitable carrier. In this regard, nanotechnology offers a wide
portfolio of nanocarriers including dendrimers, micelles, lipo-
somes, solid lipid nanoparticles, nanoemulsions and other
forms of lipophilic aggregates as well as natural systems, such
as apoferritin, lipoproteins, viral capsids and even cells.[5, 6] Im-
portant properties to be considered for the selection of the
most appropriate nanocarrier are size, biocompatibility and
biological stability.[7]
Among the above-cited nanosystems, liposomes combine
several particular favourable properties. They are nanovesicles
(typical size between 50 and 200 nm) formed by a unilamellar
phospholipid-based bilayer entrapping an aqueous core. The
main advantages of liposomes are: 1) high biocompatibility;
2) easiness of preparation; 3) great chemical versatility (ability
to be loaded with hydrophobic, amphiphilic and hydrophilic
substances) ; 4) simplicity of decorating the surface (with tar-
geting vectors, blood lifetime modulators, drugs, diagnostic
tracers and so forth) ; and 5) a longstanding and well-estab-
lished clinical use as drug-delivery carriers.[8] In analogy to all
the other nanocarriers, liposomes can also distribute passively
in pathological areas characterised by an altered endothelial
permeability, such as solid tumours, atherosclerotic plaques
and inflammation sites, through the so-called enhanced per-
meability and retention (EPR) mechanism.[9] For all these rea-
sons, liposomes are excellent candidates for developing highly
sensitive MRI agents, especially in the emerging field of thera-
nosis.[10] There are two main approaches to design liposomal
MRI agents depending on whether the imaging reporter is en-
capsulated in the aqueous core or incorporated in the bilayer.
The latter option appears preferable if one seeks high-sensitivi-
ty systems. In fact, it is well established that the relaxivity of
a paramagnetic centre, especially at magnetic field strengths
higher than 0.1 T, is mainly controlled by the rotational tum-
bling (tR) of the complex, which is correlated to the size of the
nanocarrier and the overall rigidity of the agent–nanosystem
linkage.[5] To facilitate the incorporation of the paramagnetic
chelate into the liposome bilayer, an appropriate balance be-
tween the hydrophilic and the hydrophobic portions of the
agent is necessary. So far, two types of amphiphilic paramag-
netic complexes have been investigated and used to a great
extent. These are based on: 1) an acyclic diethylenetriamine-
pentaacetic acid (DTPA)-like cage in which the linkage of two
aliphatic chains involves the transformation of two terminal co-
ordinating carboxylates into amide functionalities (e.g. , DTPA–
bovine serum albumin);[8, 11,12] or 2) a macrocyclic 1,4,7,10-tet-
raazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-like cage
in which the hydrocarbon tails are conjugated through an
amide linkage to a single coordinating carboxylate.[8, 12,13] DTPA
amides have been used extensively because of the relative
ease of syntheses, but their GdIII complexes are characterised
by a relatively low thermodynamic and kinetic stability, which
prevents their clinical translation. In addition, the transforma-
tion of two carboxylic groups into carboxoamides inevitably
causes a remarkable elongation of the exchange lifetime (tM)
of the water molecule coordinated to the paramagnetic ion,
which negatively affects the relaxivity enhancement expected
upon slowing down the rotational motion of the agent.[11] Con-
versely, monofunctionalised DOTA-like structures possess mark-
edly higher thermodynamic and kinetic stabilities and exhibit
good ability to generate contrast. The relaxivity of such agents
can be further improved through a rational design of the con-
jugation linkage between the complex and the aliphatic tails.
Another important property that influences the clinical poten-
tial of these agents is represented by the body clearance rate.
Typically, the amphiphilic agents developed so far contain C16
or C18 hydrocarbon tails that stabilise the liposomal incorpora-
tion, but confer an undesirable very slow clearance from the
tissues where the liposomes accumulate, especially in liver and
spleen. Recently, a new amphiphilic GdDOTA-like agent bear-
ing shorter hydrophobic chains (C12), suitably designed to
display optimal tM and tR values, was proposed (Scheme 1).
[14]
The presence of two aliphatic chains on adjacent coordinating
arms was conceived to reduce considerably the local rotational
motion of the GdIII chelates incorporated in the liposome bi-
layer.
In this work, we investigated the in vitro (relaxometry) and
in vivo (melanoma tumour model on mice) MRI performance
of liposomes incorporating either this complex (LIPO-GdDOTA-
(GAC12)2) (LIPO= liposome, GA=glutaric acid) or an amphiphil-
ic monoamide GdIII agent conjugated with C18 chains (LIPO-
GdDOTAMA(C18)2) as a reference.
[13] The two complexes are
shown in Scheme 1.
Scheme 1. The amphiphilic GdIII complexes investigated in this work.
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Results and Discussion
In vitro relaxometric characterisation of the liposomal
agents
The magnetic field dependence of the longitudinal 1H relaxivity
of the two paramagnetic liposomes was measured at 298 K
over the range 2.343104–1.645 T, which corresponds to
proton Larmor frequencies varying between 0.01 and 70 MHz.
The experimental data are shown in Figure 1 and constitute
the so-called nuclear magnetic relaxation dispersion (NMRD)
profiles, characterised by well-defined amplitude and shape
representing a sort of fingerprint that describes the relaxomet-
ric behaviour of the sample. The NMRD profiles of LIPO-
GdDOTA(GAC12)2 and LIPO-GdDOTAMA(C18)2 clearly show
a marked relaxivity difference over the entire frequency range
investigated, and their shape is rather similar and typical of
macromolecular systems characterised by a reduced rotational
tumbling rate.[3,5]
We can distinguish: 1) a region of constant relaxivity at low
fields (0.01–0.5 MHz); 2) a dispersion around 1–3 MHz; 3) a
peak centred about 20–30 MHz; and 4) a steep decrease of r1
at higher fields. However, although for LIPO-GdDOTAMA(C18)2
the r1 peak (r1=11.4 mm
1 s1) is broad and centred at 30 MHz,
for LIPO-GdDOTA(GAC12)2 it is narrower and with a maximum
at 20 MHz (r1=40.0 mm
1 s1). The Dr1 between the two para-
magnetic liposomes is large and shows a tendency to decrease
slightly with increasing frequency: it assumes the value of ap-
proximately 30 mm1 s1 at 0.01 MHz, 28 mm1 s1 at 20 MHz
and 21 mm1 s1 at 60 MHz. These results highlight clearly the
superior relaxometric performance of the liposomes loaded
with GdDOTA(GAC12)2 relative to the liposome formulation
based on the GdDOTAMA(C18)2 complex. This difference repro-
duces well that observed in micellar systems formed by these
two lipophilic complexes, that is, r1=30.9 mm
1 s1 for
GdDOTA(GAC12)2
[14] and approximately 20 mm1 s1 for
GdDOTAMA(C18)2,
[13] at 20 MHz and 310 K. In qualitative terms,
we can explain the difference in relaxivity on the basis of the
different rates of bound water exchange (kex=1/tM) of the
complexes and of the different degree of local rotational flexi-
bility (tRL). The residence lifetime tM is known to be significant-
ly different for this type of DOTA-like complex: at 298 K the
anionic complex typically exhibits values of the order of 100–
300 ns, whereas the neutral complex is characterised by values
that are longer by a factor of 3–4. It is well recognised that
a long tM value (0.5 ms) may severely limit the relaxivity, espe-
cially when the complex has a restricted rotational motion.[5,15]
The occurrence of a local rotational motion about the linker
connecting the coordination cage of the Gd chelate and the
anchoring site on the nanoparticle represents a second rele-
vant factor that limits the r1 of macromolecular systems. The
local motion is usually much faster than the global rotation of
the nanoparticle (tRL<tRG), thus giving rise to a shorter effec-
tive tR that lowers r1. From this perspective, a reduced rotation-
al flexibility is expected for GdDOTA(GAC12)2 in which the two
aliphatic chains are positioned on two adjacent acetic arms,
therefore achieving the so-called multisite attachment.[14,16]
For a more accurate and quantitative interpretation aimed
at identifying in detail the reasons for the different relaxivity of
the two systems, we need to analyse the observed NMRD pro-
files in terms of the paramagnetic relaxation theory. Typically,
the data are fitted by using the equations for the inner (IS) and
outer hydration sphere (OS) contributions to relaxivity.[3b] The
former arises from the time-dependent dipolar interaction be-
tween the electron (GdIII) and nuclear (protons of the coordi-
nated water molecule) magnetic moments and is based on the
classical Solomon–Bloembergen–Morgan (SBM) theory.[3] The
time modulation involves rotation of the complex (tR), electron
magnetic moment relaxation (T1,2e) and chemical exchange of
the bound water molecule with bulk water (kex). The second
contribution, determined by solvent molecules diffusing near
the paramagnetic complex, depends on the relative diffusion
coefficient D of solute and solvent molecules and their dis-
tance of closest approach a, and it is described by Freed’s
equation.[17] The OS contribution is much smaller than the IS
relaxivity and in a first approximation could be neglected.
However, the direct application of the SBM and Freed theories
is not entirely justified in the case of liposomes in which there
are contributions to r1 derived either from the complexes that
point towards the interior of the vesicles or by complexes with
the coordination cage pointing outwards, that is [Eq. (1)]:
r1 ¼ R1pIN þ R1pOUT ð1Þ
For this reason, we have developed a model that explicitly
takes into account these two conditions.
The basic concept is that the GdIII complexes exposed on
the external leaflet of the bilayer directly affect the nuclear
magnetic relaxation rate of the bulk water protons, which are
by far the predominant fraction of water in the liposomal sus-
pension (>98% under the experimental conditions used in
this work). Hence, for monoaqua complexes such as those con-
sidered herein [Eq. (2)]:
Figure 1. 1H NMRD profiles of LIPO-GdDOTAMA(C18)2 (*) and LIPO-GdDOTA-
(GAC12)2 (^) at 298 K.
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ROUT1p ¼
cOUTGd  103
55:6
 1
T1M þ tM
 
þ ROUT1OS ð2Þ
in which cGd
OUT is the molar fraction of the Gd complex point-
ing outward of the liposomes, T1M is the relaxation time of the
protons of the Gd-bound water molecule, tM is their mean resi-
dence lifetime, and R1OS
OUT is the outer-sphere relaxivity contri-
bution. Both IS and OS contributions were modelled according
to the classical SBM and Freed theories, suitably modified
using the model-free Lipari–Szabo description of the rotational
dynamics.[19] This allows the separation of the local molecular
rotation of the chelates (characterised by the correlation time
tRL) from the global tumbling motion of the nanoparticle (tRG).
The degree of correlation between the two types of motion is
described by the order parameter S2 (0<S2<1).
On the other hand, the relaxivity contribution to the bulk
water compartment from the Gd complexes pointing inward
of the liposomes, R1p
IN, can be described on the basis of the
model first proposed by Fossheim et al. ,[19] suitably adapted to
the case of a paramagnetic agent incorporated into the bilay-
er.
According to this model, bulk water protons receive a relaxa-
tion contribution from the water protons in the inner core of
the vesicles that is proportional to the volume fraction of the
intra-liposomal pool (cINTRALIPO), and dependent on both the re-
laxation time of the protons entrapped in the liposomes
(T1
INTRALIPO) and their residence lifetime in the vesicles (tINTRALIPO)
[Eq. (3)]:
RIN1p ¼
cINTRALIPO
T INTRALIPO1 þ tINTRALIPO
 
ð3Þ
T1
INTRALIPO can be described in close analogy to what was re-
ported for R1p
OUT [Eq. (2)] , but considering that in the present
case the amount of water in the compartment that contains
the Gd complexes pointing inward of the vesicles (cGd
IN) corre-
sponds to (cINTRALIPO55.6) [Eq. (4)]:
1=T INTRALIPO1 ¼
cINGd  103
cINTRALIPO  55:6
1
T1M þ tM
 
þ RIN1OS
 
ð4Þ
If tINTRALIPO is negligible with respect to T1
INTRALIPO, Equa-
tions (3) and (4) can be rearranged to give Equation (5), which
assumes exactly the same form of Equation (2) and corre-
sponds to the situation occurring when only a single water
pool is present:
RIN1p ¼
cINGd
55:6
 1
T1M þ tMð Þ
 
þ ROUT1OS ð5Þ
Considering a homogeneous distribution of the amphiphilic
complexes within the unilamellar bilayer, cIN and cOUT should
correspond to the surface ratio between the inner and the
outer leaflet.
For a sphere with an outer radius of 70 nm and a membrane
thickness of 4 nm, such a ratio is equal to 1.16, thereby yield-
ing values of 0.46 and 0.54 for cIN and cOUT, respectively.
cINTRALIPO can be calculated by the product between the volume
of water entrapped in a single vesicle (Vsingle
INTRALIPO) and the
number of vesicles (NLIPO) contained in a unitary volume of the
suspension [Eq. (6)]:
V INTRALIPOtotal ¼ V INTRALIPOsingle  NLIPO ð6Þ
Vsingle
INTRALIPO is calculated from the external diameter of the
vesicles as determined by dynamic light scattering (140 nm for
both the samples investigated in this work) subtracted from
the value of the bilayer thickness (4 nm).
NLIPO is estimated on the basis of the surface area occupied
by the components of the membrane [Eq. (7)]:
NLIPO ¼
Stotal
Ssingle
ð7Þ
The surface occupied by the membrane components of
a single unilamellar liposome (Ssingle) can be assumed as the
sum of the inner and outer leaflets of the bilayer.
mThe total surface occupied by the membrane components
(Stotal) can be estimated using the molecular surface area of the
individual components and considering their concentration in
the suspension. Under the assumption that the effective com-
position of the liposomes reflects the formulation (i.e. , molar
ratio 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)/cho-
lesterol (Chol)/Gd complex (GdL)/1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000
(DSPE-PEG2000) (L=generic ligand) corresponding to
55:30:10:5), and considering a 1 mm total concentration of the
incorporated Gd complexes, the millimolar concentration for
the membrane components (the phospholipids DPPC and
DSPE-PEG2000 were considered to contribute equally) in the
suspension are [Eq. (8)]:
½GdL¼ 1mm; ½DPPCþ DSPE-PEG2000 ¼ 1 60
10
¼ 6mm; ½Chol ¼ 1 30
10
¼ 6mm
ð8Þ
Using a millimolar surface area of 3.51020, 2.31020 and
4.81020 nm2 for phospholipids, cholesterol, and Gd com-
plexes, respectively,[20] the total membrane surface can be ob-
tained from [Eq. (9)]:
Stotal ¼
X
Si i½  ð9Þ
Here, Si refers to the millimolar surface area of the i-th compo-
nent, and [i] is its millimolar concentration.
Finally, the residence lifetime of the water protons in the
inner core of the vesicles (tINTRALIPO) is dependent on the water
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permeability of the liposome bilayer (PW) and the vesicle size
[Eq. (10)]:
tINTRALIPO ¼ rinner
3 PW ð10Þ
During the analysis of the NMRD profiles, the values of size,
membrane thickness and the molar fraction of the membrane
components were kept fixed. NMRD profiles were fitted only in
the high-field region (>2 MHz) because of the known limita-
tions of SBM theory to properly account for the behaviour of
slowly tumbling systems at low magnetic field strengths.[21]
The least-squares fitting of the data was performed by treating
as variable parameters D2, tV, ,tRG, tRL , tRM, S
2 and PW. In addi-
tion, each parameter was allowed to vary only within a reasona-
ble range of values typical of GdIII complexes.
The results of the best-fit analyses are shown in Figure 2 for
the two liposomal preparations investigated in this work and
the values of the best-fit parameters are reported in Table 1.
Confirming the qualitative analysis made earlier, the results
of the fitting prove that the residence lifetime tM is the param-
eter most affected by the nature of the GdIII complex incorpo-
rated in the liposomes. The correlation between the structure
of the chelate and the exchange rate of the coordinated water
molecule has been thoroughly investigated in the recent past,
so we can attribute the large difference observed to the differ-
ent chemical nature of the donor atoms in the two chelates. In
fact, the substitution of a carboxylic group with an amide
moiety invariantly leads to a lengthening of tM as a result of
the variation of the residual electrostatic charge from 1
(GdDOTA(GAC12)2) to 0 (GdDOTAMA(C18)2). However, it cannot
be excluded that other additional factors (e.g. , steric hindrance
at the water binding site, structural effects caused by the in-
corporation in the liposome bilayer and so forth) may also con-
tribute to the observed tM values, even though the value ob-
tained for LIPO-GdDOTA(GAC12)2 is quite similar to that report-
ed for the water-soluble analogue (100 ns).[14] For these Gd-
based macromolecular systems the parameters for electronic
relaxation (D2, tV) are simply empirical fitting parameters and
do not assume a well-defined physical meaning. However, it
can be noted that both parameters have a smaller value in the
case of GdDOTA(GAC12)2, in line with many empirical observa-
tions made on DOTA-like complexes and DOTA monoamide
derivatives.[3c,22] As discussed earlier, the poor motional cou-
pling between the paramagnetic unit and the nanoparticle is
very relevant and markedly affects the relaxivity enhancement
attainable. In fact, although the global rotation is quite similar
for the two paramagnetic liposomes, the degree of local rota-
tional motion is significantly higher in the case of LIPO-
GdDOTAMA(C18)2 (tRL=0.44 vs. 1.70 ns) as also clearly indicated
by the difference in the order parameter S2.
As far as the water permeability of the liposome bilayer is
concerned, the much higher (almost one order of magnitude)
value obtained for the bilayer embedded with GdDOTA(GAC12)2
is noteworthy. This finding confirms previous observations indi-
cating that the incorporation of amphiphilic chelates with lipo-
philic tails in different positions of the ligand favours an in-
crease of the water diffusivity across the bilayer.[23]
In vivo MRI comparison between the liposomal agents on
an experimental tumour model
On the basis of the promising in vitro results, we deemed it of
interest to compare the in vivo performance of the two liposo-
mal agents on an MRI scanner operating at 1 T (40 MHz). The
experimental protocol consisted of injecting 200 mL of the lipo-
somal suspension containing 0.05 mmol Gdkg1 body weight
in the tail vein of mice bearing a subcutaneous syngeneic B16
melanoma. The T1 contrast was then monitored over time in
selected organs (liver, spleen, kidneys and tumour).
Figure 3 shows three morphological T2w MRI images of a rep-
resentative mouse acquired before injecting the liposomal
agents, to display the attainable anatomical resolution in moni-
toring the contrast in the organs of interest (tumour, liver,
spleen and kidneys).
Figure 4 illustrates some representative T1w images acquired
10 min after the administration of the paramagnetic liposomes.
A general brightening owing to the presence of the paramag-
Figure 2. 1H NMRD profiles at 25 8C of paramagnetic liposomes incorporat-
ing GdDOTAMA(C18)2 (*) and GdDOTA(GAC12)2 (*).
Table 1. Relaxation parameters (at 25 8C) obtained from the analysis of
the NMRD profiles reported in Figure 2.[a]
Parameter GdDOTAMA(C18)2 GdDOTA(GAC12)2
D2 [1019 s2] 0.810.1 0.650.1
tV [ps] 295 114
tRG [ns] 828 7810
tRL [ns] 0.440.2 1.700.3
tM [ns] 76945 12015
S2 0.390.09 0.640.12
Pw [10
5 cms1] 1.20.5 151.5
[a] The parameters for electronic relaxation (D2, tV) were used as empirical
fitting parameters and do not have a precise physical meaning for these
macromolecular systems. The distance of the coordinated water molecule
from the metal ion (rGdH) was fixed to 3.0 . The outer-sphere compo-
nent of the relaxivity was estimated by using standard values for the dis-
tance of closest approach a (4 ) and the relative diffusion coefficient D
of solute and solvent (2.24105 cm2s1).
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netic species is detectable in liver, spleen and kidneys. An ac-
curate comparison between the imaging performances of the
two agents is possible by means of a careful assessment of the
T1 contrast enhancement in the various organs. Figure 5 sum-
marises the obtained results. A first clear piece of evidence is
that the contrast detected up to 4–5 h after the injection of
the liposomes loaded with GdDOTA(GAC12)2 was much higher
than the corresponding values measured in all the considered
organs for the nanovesicles loaded with GdDOTAMA(C18)2.
Under the reasonable assumption that the biodistribution of
the two types of liposomes in
the organ is almost identical
(justified by the same size of the
two vesicles), the superior MRI
detectability of LIPO-GdDOTA-
(GAC12)2 was about two-fold,
consistent with the four-fold
higher relaxivity observed in vi-
tro. It is likely that such a differ-
ence may be explained in terms
of: 1) the different temperatures
between in vitro (25 8C) and in vivo (32–338 for an anesthetised
mouse)[24] conditions; 2) the in vivo compartmentalisation ef-
fects (the agent is not homogeneously distributed among the
biological compartments of the tissue) ; and 3) the fact that the
signal is weighted on T1 and thus not uniquely dependent on
the effective T1. All these factors can contribute to reduce the
in vivo performance of the MRI probe.
Figure 5 shows the changes of T1 contrast over time. The en-
hancement observed for LIPO-GdDOTA(GAC12)2 decreased
markedly after about 7 h, significantly more rapidly than for
LIPO-GdDOTAMA(C18)2. Remarka-
bly, at about 10 h post-injection
the LIPO-GdDOTA(GAC12)2 con-
trast enhancement is lower than
that of the less efficient agent.
The rapid T1 contrast decrease
showed by LIPO-GdDOTA-
(GAC12)2 suggests a faster clear-
ance rate of the incorporated
agent, or it could be caused by
an intra-organ liposome degra-
dation with formation of para-
magnetic species of lower relax-
ivity.
To gain more insight into
these hypotheses, the amount of
the paramagnetic ion was mea-
sured by inductively coupled
plasma mass spectrometry (ICP-
MS) on organs explanted 1.5, 5
and 24 h post-injection of the
liposomes. The data are reported
in Figure 6. The amount of Gd
found in the organs (normalised
to the organ weight) for the two
agents at 1.5 h post-injection
was similar in liver and kidneys,
whereas some small differences
were detected in spleen and
tumour. Figure 7 reports the
comparison between the per-
centage variation of MRI contrast
and ICP-MS data, both taken at
1.5 h post-injection, of LIPO-
GdDOTA(GAC12)2 over LIPO-
GdDOTAMA(C18)2 agents (i.e. ,
Figure 3. 1 T MRI T2w images of three axial slices of a mouse prior to the injection of the paramagnetic liposomes.
The organs circled in red are: tumour (A), kidney (B), spleen (C) and liver (D).
Figure 4. MRI T1w images. A) Pre-injection, (B) 10 min after injection of GdDOTA(GAC12)2-loaded liposomes,
(C) 10 min after injection of the GdDOTAMA(C18)2-loaded liposomes.
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[(MRIC12MRIC18)/MRIC18]100). The bar plot highlights the cor-
relation between the relative quantification (ICP-MS) and con-
trast efficiency (MRI) of the two agents. For instance, in kid-
neys, the two liposomes displayed a quite similar Gd concen-
tration, with a little preference for LIPO-GdDOTAMA(C18)2. How-
ever, the use of nanovesicles loaded with GdDOTA(GAC12)2 led
to a much higher contrast. This finding is a clear indication of
the intrinsic higher relaxometric efficacy of this amphiphilic
probe. Surprisingly, the organs of the mononuclear phagocyte
system, that is, spleen and liver, showed a preferential avidity
for LIPO-GdDOTAMA(C18)2, but the MRI contrast observed for
LIPO-GdDOTA(GAC12)2 was still higher and, moreover, it was
well correlated with the decrease of the differential uptake be-
tween LIPO-GdDOTA(GAC12)2 and LIPO-GdDOTAMA(C18)2 ob-
served on passing from liver to spleen. Most likely the reduced
localisation in liver and spleen allowed a preferential accumula-
tion of LIPO-GdDOTA(GAC12)2 agent in the tumour, for which
the agent showed the highest contrast enhancement (ca.
250%) relative to LIPO-GdDOTAMA(C18)2.
As far as the clearance rate is concerned, the data reported
in Figure 6 indicate that GdDOTA(GAC12)2 is eliminated much
faster than the agent with the longer aliphatic chains, with the
exception of kidneys, for which the two systems showed simi-
lar kinetic profiles. Graphically, this result can be better repre-
sented as the ratio between the amount of Gd determined by
ICP-MS at 5 and 24 h normalised to the value obtained at 1.5 h
post-injection (Figure 8). The data reported in the plot high-
light the difference in the kinetic behaviour for the two liposo-
Figure 5. Time evolution of the T1 contrast enhancement in the indicated organs after injection of paramagnetic liposomes incorporating GdDOTAMA(C18)2
(*) and GdDOTA(GAC12)2 (*).
Figure 6. Amount of gadolinium measured by ICP-MS, normalised to the
organ weight, found for the different organs excised from mice injected
with LIPO-GdDOTAMA(C18)2 or LIPO-GdDOTA(GAC12)2 as a function of the
time post-injection.
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mal samples in the investigated
organs. This finding is a strong
indication of the more rapid
clearance of the imaging agent
conjugated with the shorter ali-
phatic chains and with a residual
negative charge. On the other
hand, the close similarity be-
tween the kinetic profiles of the
agents in the kidneys could be
justified by a predominant intravascular distribution
in this organ with no, or negligible, renal accumula-
tion. In fact, in this case, it is reasonable to assume
that the blood circulation lifetime of the two liposo-
mal agents is similar. Thus, the different kinetic pro-
files obtained for the two complexes can allow the
identification of the tissues at which the liposomes
extravasate and accumulate.
To gain further information on the biodistribution
of the two liposomal agents, the nanovesicles were
additionally loaded with a newly synthesised amphi-
philic phospholipid-like fluorescent dye, Cy5-(C16)2,
based on cyanine fluorophore and conjugated with
two palmitic aliphatic chains (Scheme 2). The results,
expressed as nanomoles of dye per gram of organ,
are shown in Figure 9, which reports the temporal
variation of the uptake normalised to the uptake at
1.5 h (as done in Figure 8). The two preparations
were injected into tumour-bearing mice and the
organs were excised after 1.5, 5 and 24 h to be ana-
lysed by spectrofluorimetry.
The data reported in Figure 9 confirmed that liver
and spleen were the organs with the highest lipo-
some uptake. However, the excretion kinetics of the
liposome loaded with the fluorescent dye was quite
Figure 7. Variation of MRI T1 contrast and ICP-MS data calculated, at 1.5 h post-injection,
from the values reported in Figures 4 and 5 by using the following formula (in the case
of MRI): [(MRIC12MRIC18)/MRIC18]100.
Figure 8. Percentage variation of the amount of Gd determined at 5 and
24 h post-injection normalised to the value determined after 1.5 h.
Scheme 2. Chemical structure of Cy5-(C16)2 with numbering scheme adopted for
1H NMR assignment (see Experi-
mental Section).
Figure 9. Spectrophotometric quantification of GdDOTAMA(C18)2 and
GdDOTA(GAC12) liposomes loaded with Cy5-(C16)2 dye in mice organs.
Organs of treated mice were excised at different times after administration
and the fluorescence was quantified with a standard curve and normalised
to organ weight.
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similar to that determined for the dye-free liposomes loaded
with GdDOTA(GAC12)2, and different from that of GdDOTAMA-
(C18)2-loaded vesicles, especially in liver and spleen (Figures 7
and 8 versus Figures 9 and 10). This observation may indicate
that, in addition to vesicle degradation, the removal of the am-
phiphilic compounds from the organs could occur through the
separation of the hydrophilic moiety (Gd complexes or Cy5-
based dye).
According to this hypothesis, the data indicate that the sta-
bility of the linkage between lipophilic and hydrophilic por-
tions of the amphiphiles decreases in the order GdDOTAMA-
(C18)2>GdDOTA(GAC12)2Cy5-(C16)2.
Conclusion
Relatively minor differences in the molecular structure of two
amphiphilic Gd-containing agents determine marked differen-
ces in either the induced T1 contrast or the excretion pathway
on incorporating these species into liposomes.
The two considered systems contain GdDOTA-like agent
bearing short hydrophobic chains (C12), suitably designed to
display an optimal rate of water exchange and restricted local
rotational dynamics (LIPO-GdDOTA(GAC12)2), and an amphiphil-
ic GdIII agent conjugated with C18 chains (LIPO-GdDOTAMA-
(C18)2) as a reference. On embedding these complexes into the
liposome membrane, the determinants of the observed relaxiv-
ity are the occurrence of a slow tumbling motion (long tRG),
the effect of which may be eventually “quenched” by the oc-
currence of a long water residence lifetime. The T1 contrast is
markedly higher for the complex endowed with a residual neg-
ative charge, which determines a faster exchange rate for the
coordinated water molecule. In addition, a pronounced ad-
vantage in terms of restricted local mobility is observed for
GdDOTA(GAC12)2, which also plays an important role in deter-
mining the higher relaxivity.
The two Gd-loaded liposomes were then labelled
with a Cy5-based fluorescent dye (bound to a C16
phospholipid) and the excretion kinetics were similar
to those of LIPO-GdDOTA(GAC12)2 and faster than for
LIPO-GdDOTAMA(C18)2. This finding suggests that, in
addition to the stability of the incorporation in the
vesicles, the removal of the imaging probes from the
organs might occur through the detachment of the
polar portion of the amphiphiles.
Taken together, the results presented herein indi-
cate that liposomes loaded with GdDOTA(GAC12)2
may have great potential for molecular MRI by virtue
of their favourable relaxometric and pharmacokinetic
properties.
Experimental Section
Chemicals
1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine
(DPPE), 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), 1,2-distearoyl-sn-glycero-3-phosphoethanola-
mine-N-[methoxy (polyethylene glycol)-2000] ammonium
salt (DSPE-PEG2000) and cholesterol (Chol) were pur-
chased from Avanti Polar Lipids Inc. (Alabaster, AL, USA).
GdDOTAMA(C18)2 and GdDOTA(GAC12)2 complexes were synthesised
according to the procedures reported in references [13] and [14],
respectively. Cy5 dye was kindly supplied by Ferrania Technologies
S.p.A. (Cairo Montenotte, SV, Italy). All other chemicals were pur-
chased from Sigma–Aldrich. Culture medium RPMI 1640, biological
buffers, and foetal bovine serum were purchased from Cambrex,
East Rutherford, NJ.
Synthesis of Cy5-N-hydroxysuccinimide
A solution of dye Cy5 (0.200 g, 0.29 mmol) and N-hydroxysuccini-
mide (0.050 g, 0.43 mmol) in dry DMF (3 mL) was cooled to 0 8C
and a solution of N-ethyl-N’-[3-(dimethylamino)propyl]carbodiimide
hydrochloride (0.082 g, 0.43 mmol) in dry DMF (0.5 mL) was added
in 5 min. The mixture was stirred for 20 h at room temperature,
washed with water (315 mL), dried and used without further pu-
rification.
Synthesis of Cy5-(C16)2
A solution of Cy5-N-hydroxysuccinimide in dry CH2Cl2 (1 mL) was
added slowly, at room temperature, to a solution of DPPE (0.020 g,
0.029 mmol) in dry CH2Cl2 (5 mL) and triethylamine (0.029 mmol,
4 mL). The product was recovered after purification by column
chromatography (silica gel, elution gradient: CH2Cl2/MeOH 95:5!
9:1!8:2; TLC: CH2Cl2/MeOH, 9:1 (v/v), Rf=0.22) to yield a dark
blue solid. A 56% pure product was obtained (22 mg). 1H NMR
(CD3OD, 600 MHz): d=8.36 (t,
3J(H,H)=12.90 Hz, 1H; H9), 8.24 (t,
3J(H,H)=13.24 Hz, 1H; H11), 7.95 (d, 3J(H,H)=8.45 Hz, 1H; H2), 7.93
(s, 1H; H3), 7.58 (d, 3J(H,H)=7.99 Hz, 1H; H4), 7.51 (m, 2H; H6, H7),
7.35 (m, 2H; H1,H5), 6.75 (t, 3J(H,H)=12.23 Hz, 1H; H10), 6.60 (d,
3J(H,H)=13.87 Hz, 1H; H8), 6.26 (d, 3J(H,H)=13.48 Hz, 1H; H12),
5.25 (s, 1H; glycerol), 4.46 (d, 3J(H,H)=13.19 Hz, 2H), 4.30 (m, 2H),
4.21 (m, 2H), 4.10 (m, 2H), 4.01 (m, 2H), 3.92 (m, 2H), 3.41 (m, 2H),
2.92 (m, 2H), 2.34 (m, 4H), 2.26 (m, 2H), 2.06 (m, 2H), 1.98 (m, 2H),
1.84 (m, 2H), 1.78 (s, 12H; CH3 indole), 1.73 (m, 2H), 1.61 (m, 4H),
Figure 10. Percentage variation of the amount of Cy5-(C16)2 determined at 5 and 24 h
post-injection with respect to the uptake determined after 1.5 h.
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1.50 (m, 2H), 1.30 (m, 48H), 0.93 ppm (m, 6H; CH3, C16 chain); ESI-
MS: m/z calcd (M+H+) 1356.78; found: 1356.77.
Liposome preparation
Long-circulating liposomes were prepared as described previous-
ly.[14] The total amount of phospholipids and amphiphilic complex
was 60 mgmL1. Briefly, appropriate amounts of DPPC, cholesterol,
DSPE-PEG2000, and GdDOTAMA(C18)2 or GdDOTA(GAC12)2 in
a molar ratio of 55:30:5:10, respectively, were dissolved in chloro-
form/methanol (95:5 by volume) in a round-bottomed flask. A lipid
film was prepared after slow solvent removal under reduced pres-
sure on a rotary evaporator. The film was then dried under
a stream of nitrogen for 2 h. Liposomes were formed by adding an
isotonic buffer at pH 7.4, composed of 10 mm 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) and 135 mm NaCl, to the
lipidic thin film. The hydration was performed at 55 8C and was ac-
companied by vigorous shaking. The obtained suspension was ex-
truded several times (Lipex extruder, Northern Lipids Inc.) through
polycarbonate filters with progressively reduced pore diameters
from 400 to 100 nm. Liposomes were dialysed briefly (4 h) to
remove any non-incorporated material. The mean hydrodynamic
size of the liposomes was determined by dynamic light scattering
(Zetasizer Nano 90 ZS, Malvern, UK) and was found to be around
140 nm with a polydispersity index value lower than 0.2. The total
concentration of the paramagnetic complexes in the liposome sus-
pension was determined by magnetic susceptibility measure-
ments.[14]
1H NMR relaxation measurements
The magnetic field dependence of the water proton longitudinal
relaxation rates for the buffered (see above) suspensions of the
paramagnetic complexes incorporated in the liposomes were mea-
sured on a fast field-cycling Stelar SmarTracer relaxometer (Stelar
s.r.l. , Mede, Pv, Italy) over a continuum of magnetic field strengths
from 0.00024 to 0.25 T (corresponding to 0.01–10 MHz proton
Larmor frequencies). The relaxometer was operated under comput-
er control with an absolute uncertainty in 1/T1 of 1%. Additional
data points in the range 15–70 MHz were obtained on a Bruker
WP80 NMR electromagnet adapted to variable-field measurements
(15–80 MHz proton Larmor frequency) with a Stelar relaxometer.
The exact concentration of GdIII was determined by measurement
of bulk magnetic susceptibility shifts of a tBuOH signal. The 1H T1
relaxation times were acquired by the standard inversion recovery
method with a typical 908 pulse width of 3.5 ms and 16 experi-
ments of four scans. The reproducibility of the T1 data was 5%.
The temperature was controlled with a Stelar VTC-91 airflow heater
equipped with a calibrated copper–constantan thermocouple (un-
certainty of 0.1 8C).
Cells
B16.F10 murine melanoma cells were cultured as monolayers at
37 8C in a 5% CO2-containing humidified atmosphere in RPMI 1640
medium supplemented with 10% (vol/vol) heat-inactivated foetal
calf serum, 100 IUmL1 penicillin and 100 mgmL1 streptomycin.
Mouse model
Male C57Bl/6 mice (6–8 weeks of age) were obtained from Charles
River Laboratories (Calco, Italy) and kept in housing with standard
rodent chow and water available ad libitum, and a 12 h light/dark
cycle. Experiments were performed according to the national regu-
lations and were approved by the local animal experiments ethical
committee. For tumour induction, 1 million B16.F10 melanoma
cells dispersed in phosphate-buffered saline (0.2 mL) were inoculat-
ed subcutaneously in the right flank of the mouse. Around 1 week
after cell inoculation, the mice developed solid tumours of size
around 20 mm3 and they were subjected to imaging experiments.
For MRI acquisition, the mice were anaesthetised by injecting tilet-
amine/zolazepam (20 mgkg1; Zoletil 100; Virbac, Milan, Italy) and
xylazine (5 mgkg1; Rompun; Bayer, Milan, Italy). Mice received
a single intravenous injection (caudal vein) of liposomes corre-
sponding to 0.05 mmol Gd kg1 body weight.
MRI measurements
The animals (four for each liposomal preparation) were subjected
to MRI investigation before injection of Gd–liposomes, within 2 h
post-injection, and then after 6, 24 and 48 h. MR images were ac-
quired at 1 T on an Aspect M2 High-Performance MRI System
(Aspect Magnet Technologies Ltd. , Netanya, Israel), mounted with
a NdFeB permanent magnet with a field homogeneity of 0.2–0.5 G.
This system was equipped with a 35 mm solenoid Tx/Tr coil (inner
diameter 35 mm) and fast gradient coils (gradient strength:
450 mTm1 at 60 A; ramp time: 250 ms at 160 V). MR images were
acquired using a standard T1-weighted multislice spin-echo se-
quence, with a flip angle of 908, repetition time (TR)/time to echo
(TE)/number of acquisitions (NEX)=200:6:10, field of view (FOV)=
4.04.0 cm, data matrix 128128, slice thickness 1.5 mm, interslice
distance 0.1 mm, slice number 11. T1 contrast was calculated as
a percentage (T1
enh%, enh=enhanced) by using Equation (11):
Tenh1 % ¼
IPOST  IPRE
IPRE
 100 ð11Þ
in which IPRE and IPOST are the MR signal intensity of a manually
drawn region of interest, normalised with respect to an external
reference, before and after the intravenous injection of the lipo-
somes, respectively. Contrast was measured in liver, spleen, tumour
and kidneys.
Ex vivo determination of liposome biodistribution
To evaluate the biodistribution of the injected liposomes and the
MRI data obtained in parallel, the amount of material delivered by
the nanovesicles to the given organs was determined ex vivo after
excising liver, spleen, kidneys and tumour. Two analytical methods
were used: spectrofluorimetry and ICP-MS. The former approach
required the incorporation of Cy5-(C16)2 fluorescent dye in the lipo-
some bilayer (5% in moles of the lipid components). The amount
of GdIII distributed in the organs over time was determined by ICP-
MS. Each excised organ was weighed, chopped with a scalpel,
placed in a vial with a solution of methanol and chloroform
(50:50), and finally homogenised with Ultra-Turrax. A series of cen-
trifugations were performed to give a clear solution. Then, each so-
lution was subjected to spectrofluorimetric analysis (FluoroMax-4,
Horiba Jobin Yvon) and the concentration was read from a calibra-
tion curve of the dye dissolved in chloroform/methanol. The dye
was excited at 650 nm and fluorescence was detected at 671 nm.
As the fluorescent dye can primarily act as reporter of the lipo-
some distribution, it is important to evaluate directly the amount
of gadolinium distributed in the organs over time. ICP-MS (ELAN
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6100, PerkinElmer) was selected as a highly sensitive analytical
technique to achieve this objective. The samples were mineralised
in a microwave vessel (Mars-5 Xpress, C.E.M.) by using nitric acid
60%.
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